Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-20

FDA Approved: HEPARIN SODIUM AND DEXTROSE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hospira's Heparin Sodium and Dextrose (heparin sodium) product, authorizing changes under the NDA. The action confir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM)

Snippet

SUPPL AP for HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM)